Clinical Advantages of the Aerosol Route of Drug Administration

Svedmyr N , Lofdahl C-G . Physiology and pharmacodynamics of beta-adrenergic agonists. In: Jenne JW , Murphy S , eds. Drug therapy for asthma: research and clinical practice. New York: Marcel Dekker Inc, 1987: 177–211.

Robillson BF , Epstein SE , Beiser GD , Braunwald E. Control of heart rate by the autonomic nervous system. Circulation Res 1966;19:400–411.

Svedmyr N , Thiringer G. The effects of salbutamol and isoprenaline on beta-receptors in patients with chronic obstructive lung disease. Postgrad Med J 1971;47:44–46.

Thiringer G , Svedmyr N. Comparison of infused and inhaled terbutaline in patients with asthma. Scand J Respir Dis 1976;57:17–24.

Arnold JM , McDevitt DG . Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine. Br J Clin Pharmacol 1983;16:175–184.

Brown JE , McLeod AA , Shand W. Evidence for cardiac adrenoceptors in man. Clin Pharmacol Ther 1983;33:424.

Stiles GL , Taylor S , Lefkowitz RJ . Human cardiac beta-adrenergic receptors: sub-type heterogeneity delineated by direct radioligand binding. Life Sci 1983;33:467–473.

Svedmyr N. Treatment with beta-adrenostimulants. Scand J Respir Dis 1977;101(Suppl):59–69.

Karlsson J-A , Persson CG . Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline. Br J Pharmacol 1981;74:73–79.

Raffestin B , Cerrina J , Boullet C , Labat C , Benveniste J , Brink C. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exper Ther 1985;233:186–194.

Jenne JW , Shaughnessy TK , Druz WS , Manfredy CJ , Westal RE . In vivo functional antagonism between isoproterenol and bronchoconstrictance in the dog. J Appl Physiol 1987;63:812–819.

Van Amsterdam RGM , Meurs H , Ten-Berge REJ , Veninga NC , Brouwer F , Zaagsma J. Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by beta-adrenoceptor agonists. Am Rev Respir Dis 1990; 142:1124–1128.

Paterson JW , Evans RJC , Prime FJ . Selectivity of bronchodilator action of salbutamol in asthmatic patients. Br J Dis Chest 1971;65:21–38.

McEvoy JDS , Vall-Spynosa A , Paterson JW . Assessment of orciprenaline and isoproterenol infusions in asthmatic patients. Am Rev Respir Dis 1973;108:490–500.

Janson C. Inhaled and intravenous salbutamol: a study of plasma levels and effects. Eur J Respir Dis (in press) 1991.

Tandom MK . Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest 1980;77:429–431.

Brittain RT , Dean CM , Jack D. Sympathomimetic bronchodilator drugs. Pharmacol Ther Bull 1976;2:423–462.

Flatt A , Crane J , Purdie G , Kwong T , Beasley R , Burgess C. The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J 1990;66:98–101.

Windom HH , Burgess CD , Siebers RWL , Purdie G , Pearce N , Crane J , . The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma. Clin Pharmacol Ther 1990;48:296–301.

Dulfano MJ , Glass P , McPhillips JJ . A comparison of the bronchodilator effects of the same amounts of terbutaline aerosol given as a single or in divided doses. Ann Allergy 1977;39:266–271.

Heimer D , Shim C , Williams MH . The effect of sequential inhalations of metaproterenol aerosol in asthma. J Allergy Clin Immunol 1980;66:75–77.

Rossing TH , Fanta CH , McFadden ER Jr . Effect of outpatient treatment of asthma with beta-agonists on the response to sympathomimetics in an emergency room. Am J Med 1983;75:781–784.

Svedmyr N. Is beta-adrenoceptor sensitivity a limiting factor in asthma therapy? In: Morley J , ed. Beta-adrenoceptors in asthma. London: Academic Press, 1984:181–199.

Tattersfield AE . Tolerance to beta-agonists. Bull Eur Physiopathol Respir (Clin Respir Physiol) 1985;21 (Suppl):1S–5S.

Swedish Society of Chest Medicine. High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Eur Respir J 1990;3:163–170.

Wood DW , Downs JJ , Scheinkopf H , Lecks HI . Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus. J Allergy Clin Immunol 1972;50(2):75–81.

Downs JJ , Wood DW , Harwood I , Scheinkopf HN , Raphaly RC . Intravenous isoproterenol infusion in children with severe hypercapnia due to status asthmaticus. Crit Care Med 1973;1(2):63–68.

Parry WH , Martorano F , Cotton EK . Management of life-threatening asthma with intravenous isoproterenol infusions. Am J Dis Child 1976;130:39–42.

Herman JJ , Noah ZL , Moody RR . Use of intravenous isoproterenol for status asthmaticus in children. Crit Care Med 1983;11(9):716–720.

Matson JR , Loughlin GM , Strunk RC . Myocardial ischemia complicating the use of isoproterenol in asthmatic children. J Pediatr 1978;92:776–778.

Kurland G , Williams J , Lewiston NJ . Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma. J Allergy Clin Immunol 1979;63:407–411.

Maguire JF , Geha RS , Umetsu DT . Myocardial specific creatine phosphokinase isoenzyme elevation in children with asthma treated with intravenous isoproterenol. J Allergy Clin Immunol 1986;78(4, Part 1):631–636.

Fitchett DH , McNichol MW , Riordan JF . Intravenous salbutamol in management of status asthmaticus. Br Med J 1975;1:53–55.

Nogrady SG , Hartley JPR , Seaton A. Metabolic effects of intravenous salbutamol in the course of severe asthma. Thorax 1977;32:559–562.

Boe J , Carlsson L-G , Hetta L , Karlson B , Ljungholm K. Acute asthma-plasma levels and effect of terbutaline I.V. injection. Eur J Respir Dis 1985;67:261–268.

May CS , Paterson JW , Spiro SG , Johnson AJ . Intravenous infusion of salbutamol in the treatment of asthma. Br J Clin Pharmacol 1975;2:503–508.

Williams SJ , Parrish RW , Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J 1975;4:685.

Femi-Pearse D , George WO , Ilechukwu ST , Elegbeleye OO , Afonja AO . Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J 1977;1:491.

Johnson AJ , Spiro SG , Pidgeon J , Bateman S , Clark SW . Intravenous infusion of salbutamol in severe acute asthma. Br Med J 1978;1:1013–1015.

Lawford P , Jones BJM , Milledge JS . Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J 1978;1:84.

Moler FW , Hurwitz ME , Custer JR . Improvement in clinical asthma score and Paon in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988;81:1101–1109.

Portnoy J , Aggarwal J. Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allergy 1988;60:368–371.

Colacone A , Wolkove N , Stern E , Afilalo M , Rosenthal TM , Kreisman H. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest 1990;97:693–697.

Kelly HW , McWilliams BC , Katz R , Murphy S. Safety of frequent high dose nebulized terbutaline in children with acute severe asthma. Ann Allergy 1990;64(Part II):229–233.

Bloomfield P , Carmichael J , Petrie GR , Jewell NP , Crompton GK . Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J 1979;1:848–850.

Edmunds AT , Godfrey S. Cardiovascular response during severe acute asthma and its treatment in children. Thorax 1981;36:534–540.

Robertson CF , Smith F , Beck R , Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr 1985;106:672–674.

Van Renterghem D , Lamont H , Elinck W , Pauwels R , Van der Straeten M. Intravenous versus nebulized terbutaline in patients with acute severe asthma: a double-blind randomized study. Ann Allergy 1987;59:313–316.

Sheong B , Reynolds S , Rajan KG , Ward MJ . A comparison of intravenous with nebulized salbutamol in the treatment of acute severe asthma. Thorax 1987;42:731.

Rossing TH , Fanta CH , Goldstein DH , Snapper JR , McFadden ER . Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis 1980;122:365–371.

Fanta CH , Rossing TH , McFadden ER . Emergency room treatment of asthma: relationship among therapeutic combinations, severity of obstruction and time course of response. Am J Med 1982;72:416–422.

Fanta CH , Rossing TH , McFadden ED . Treatment of acute asthma: is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med 1986;80:5–10.

Siegel D , Sheppard D , Gelb A , Weinberg PF . Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic in the treatment of acute exacerbations of asthma. Am Rev Respir Dis 1985;132:283–286.

Newhouse MT , Lam A. Management of asthma and chronic airflow limitation: are methylxanthines obsolete? Lung 1990;168(Suppl):634–641.

Dolovich MB , Sanchis J , Rossman C , Newhouse MT . Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol 1976;40:468–471.

Ruffin RE , Montgomery JM , Newhouse MT . Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods. Chest 1978; 74:256–260.

Weber RW , Smith KA , Nelson HS . Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration. J Allergy Clin Immunol 1982;70:417–422.

Repsher LH , Anderson JA , Bush RK , Falliers CJ , Kass F , Kemp JP , . Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol. Chest 1984;85:34–38.

Kelly HW , Murphy S. Should anticholinergics be used in acute severe asthma? Ann Pharmacother 1990;24:409–416.

Lam A , Newhouse MT . Management of asthma and chronic airflow limitation: are methylxanthines obsolete? Chest 1990;98:44–52.

Fanta CH , Rossing TH , McFadden ER Jr . Glucocorticoids in acute asthma: a critical controlled trial. Am J Med 1985;74:845–851.

Littenberg B , Gluck EH . A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 1986;314:150–152.